Novel Phospholipid Signature of Depressive Symptoms in Patients With Coronary Artery Disease
Parco Chan(Sunnybrook Health Science Centre), Krista L. Lanctôt(Sunnybrook Health Science Centre), Paul Oh(University Health Network), Dana Mohammad(Sunnybrook Health Science Centre), Lyn M. Hillyer(University of Guelph), Ivonne Suridjan(AbbVie (United States)), Nathan Herrmann(Sunnybrook Health Science Centre), Graham Mazereeuw(Toronto Rehabilitation Institute), David W.L.(University of Guelph)
Cited by 15
Related Papers
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
|JAMA Neurology|2021|627
The Impact of COVID-19 on Health Behavior, Stress, Financial and Food Security among Middle to High Income Canadian Families with Young Children
|Nutrients|2020|593
Comprehensive Profiling of Plasma Fatty Acid Concentrations in Young Healthy Canadian Adults
|PLoS ONE|2015|367
Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n‐3 and n‐6 polyunsaturated fatty acids
|Hepatology|2015|348
Are all n-3 polyunsaturated fatty acids created equal?
|Lipids in Health and Disease|2009|333